Rizwan Mahmud

Mr. Rizwan Mahmud


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
RMRizwan Mahmud
Rizwan Mahmud
ZKZoë Krullaars
Zoë Krullaars
JOJolieke Aleida Therese van Osch
Jolieke Aleida Therese van Osch
DRDavid Rickett
David Rickett
ZBZabrina L Brumme
Zabrina L Brumme
Thibault MesplèdeThibault Mesplède
Thibault Mesplède
The presentation of HIV peptides by the human leukocyte antigen (HLA) complex to CD8+ cytotoxic T-cells (CTLs) is critical to limit viral pathogenesis. HIV can mutate to evade HLA-restricted CTL responses and resist antiretroviral drugs, raising questions about how it balances these evolutionary pressures. Here, we used a computational approach to assess how drug resistance-associated mutations (RAMs) affect the binding of HIV-1 subtype B or C peptides to the most prevalent HLA alleles in US, European, and South African populations. We predict RAMs that may be favored in certain populations and report the under-representation of Y181C in people expressing HLA-B*57:01. This finding agreed with our computational predictions when Y181C was at the major anchor site P2, suggesting the potential relevance of our approach. Overall, our findings lay out a conceptual framework to study the implications of HLA alleles on the emergence of HIV RAMs at the individual and population levels.